Enzo Biochem

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Enzo Biochem and buy or sell other stocks, ETFs, and their options commission-free!

About ENZB

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company was founded by Elazar Rabbani, Barry W. 

CEO
Jason Apter
CEOJason Apter
Employees
Employees
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1976
Founded1976
Employees
Employees

ENZB Key Statistics

Market cap
36.62M
Market cap36.62M
Price-Earnings ratio
-1.73
Price-Earnings ratio-1.73
Dividend yield
Dividend yield
Average volume
77.55K
Average volume77.55K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$1.19
52 Week high$1.19
52 Week low
$0.252
52 Week low$0.252

Stock Snapshot

With a market cap of 36.62M, Enzo Biochem(ENZB) trades at $0.70. The stock has a price-to-earnings ratio of -1.73.

During the trading day, Enzo Biochem(ENZB) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 77.55K.

The stock's 52-week range extends from a low of $0.25 to a high of $1.19.

The stock's 52-week range extends from a low of $0.25 to a high of $1.19.

People also own

Based on the portfolios of people who own ENZB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.